glyoxal has been researched along with Diabetes Mellitus, Adult-Onset in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 9 (42.86) | 24.3611 |
| 2020's | 8 (38.10) | 2.80 |
| Authors | Studies |
|---|---|
| Dagnelie, PC; Eussen, SJPM; Maasen, K; Opperhuizen, A; Schalkwijk, CG; Scheijen, JLJM; Stehouwer, CDA; van der Kallen, CJH; van Greevenbroek, MMJ | 1 |
| Abidi, M; Ali, A; Habib, S; Mir, AR; Rizwee, MM; Uddin, M | 1 |
| Berendschot, TTJM; Dagnelie, PC; Eussen, SJPM; Houben, AJHM; Maasen, K; Opperhuizen, A; Schalkwijk, CG; Schram, MT; Stehouwer, CDA; van Greevenbroek, MMJ; Webers, CAB | 1 |
| Dagnelie, PC; Eussen, SJPM; Maasen, K; Opperhuizen, A; Schalkwijk, CG; Stehouwer, CDA; van Greevenbroek, MMJ | 1 |
| Alouffi, S; Khan, MWA | 1 |
| Ahmad, K; Choi, I; Lee, EJ; Lee, YH; Shaikh, S | 1 |
| Ahmad, S; Farooqui, A; Husain, A; Khanam, A; Rehman, S; Yusuf, MA | 1 |
| Hanssen, NMJ; Hovind, P; Parving, HH; Persson, F; Piazza, M; Rossing, P; Schalkwijk, CG; Scheijen, JL; Stehouwer, CDA; van de Waarenburg, MPH; van Greevenbroek, MMJ | 1 |
| Gao, WY; Li, H; Liu, ZF; Ma, SB; Wang, XJ | 1 |
| Gao, WY; Li, H; Wang, XJ; Zhang, HX; Zhu, AH | 1 |
| Schalkwijk, CG; Scheijen, JL | 1 |
| Bendszus, M; Deshpande, D; Fleming, T; Groener, JB; Hidmark, A; Mendler, M; Muckenthaler, MU; Müller, BP; Nawroth, PP; Pham, M; Reeh, PW; Sauer, SK; Vittas, S | 1 |
| Lavelli, V; Mesias, M; Morales, FJ; Sri Harsha, PS | 1 |
| Hanssen, NM; Maessen, DE; Schalkwijk, CG; Scheijen, JL; Stehouwer, CD; van der Kallen, CJ; van Greevenbroek, MM | 1 |
| Belova Kumskova, EM; Grechnikova, MA; Konovalova, GG; Lankin, VZ; Shumaev, KB; Tikhaze, AK; Viigimaa, M | 1 |
| Dmitriev, LF | 1 |
| Chen, HJ; Chen, PF; Chen, YC; Hsiao, CF | 1 |
| Basso, E; Dalla Vedova, A; Fedele, D; Flamini, R; Lapolla, A; Reitano, R; Senesi, A; Seraglia, R; Traldi, P | 1 |
| Lapolla, A; Ragazzi, E; Reitano, R; Sartore, G; Seraglia, R; Traldi, P | 1 |
| Maeda, K; Matsumoto, Y; Odani, H; Shinzato, T; Usami, J | 1 |
| Bucala, R; Kameda, Y; Koike, T; Makita, Z; Suzuki, T; Takeuchi, M | 1 |
4 review(s) available for glyoxal and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Dicarbonyls Generation, Toxicities, Detoxifications and Potential Roles in Diabetes Complications.
Topics: Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Gene Expression Regulation; Glycation End Products, Advanced; Glyoxal; Humans; Insulin; Insulin Resistance; Isoenzymes; Lactoylglutathione Lyase; Oxidative Stress; Protein Carbonylation; Pyruvaldehyde; Signal Transduction | 2020 |
Consequences of Dicarbonyl Stress on Skeletal Muscle Proteins in Type 2 Diabetes.
Topics: Deoxyglucose; Diabetes Mellitus, Type 2; Extracellular Matrix Proteins; Gene Expression Regulation; Glycation End Products, Advanced; Glyoxal; Humans; Insulin; Insulin Resistance; Isoenzymes; Lactoylglutathione Lyase; Muscle, Skeletal; Oxidative Stress; Protein Carbonylation; Pyruvaldehyde; Signal Transduction | 2020 |
Glycation and Antioxidants: Hand in the Glove of Antiglycation and Natural Antioxidants.
Topics: Antigens, Neoplasm; Antioxidants; Cardiovascular Diseases; Deoxyglucose; Diabetes Mellitus, Type 2; Gene Expression Regulation; Glycation End Products, Advanced; Glyoxal; Humans; Lactoylglutathione Lyase; Mitogen-Activated Protein Kinases; Neoplasms; NF-kappa B; Oxidative Stress; Plant Extracts; Polyphenols; Protein Carbonylation; Pyruvaldehyde; Signal Transduction | 2020 |
A new paradigm to understand and treat diabetic neuropathy.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Glycation End Products, Advanced; Glyoxal; Humans; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2014 |
1 trial(s) available for glyoxal and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-study.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Chromatography, Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Glyoxal; Humans; Irbesartan; Male; Middle Aged; Pyruvaldehyde; Tandem Mass Spectrometry; Time Factors; Treatment Outcome | 2021 |
16 other study(ies) available for glyoxal and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Higher habitual intake of dietary dicarbonyls is associated with higher corresponding plasma dicarbonyl concentrations and skin autofluorescence: the Maastricht Study.
Topics: Aged; Chromatography, Liquid; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diet; Diet Surveys; Dietary Exposure; Fasting; Female; Glycation End Products, Advanced; Glyoxal; Humans; Linear Models; Male; Mass Spectrometry; Middle Aged; Netherlands; Optical Imaging; Pyruvaldehyde; Skin | 2022 |
Characterization of Glyoxal Modified LDL: Role in the Generation of Circulating Autoantibodies in Type 2 Diabetes Mellitus and Coronary Artery Disease.
Topics: Animals; Autoantibodies; Coronary Artery Disease; Diabetes Mellitus, Type 2; Epitopes; Glyoxal; Humans; Rabbits | 2021 |
Habitual intake of dietary methylglyoxal is associated with less low-grade inflammation: the Maastricht Study.
Topics: Aged; Biomarkers; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diet; Female; Glycation End Products, Advanced; Glyoxal; Humans; Inflammation; Magnesium Oxide; Male; Middle Aged; Pyruvaldehyde; Sexually Transmitted Diseases | 2022 |
Habitual Intake of Dietary Dicarbonyls is Associated with Greater Insulin Sensitivity and Lower Prevalence of Type 2 Diabetes: The Maastricht Study.
Topics: Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glyoxal; Humans; Insulin Resistance; Magnesium Oxide; Male; Prevalence; Prospective Studies; Pyruvaldehyde | 2023 |
Elevated levels of α-dicarbonyl compounds in the plasma of type II diabetics and their relevance with diabetic nephropathy.
Topics: Aged; Biomarkers; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diacetyl; Female; Glyoxal; Humans; Male; Middle Aged; Pyruvaldehyde | 2019 |
Measurement of α-dicarbonyl compounds in human saliva by pre-column derivatization HPLC.
Topics: Adult; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glyoxal; Humans; Male; Middle Aged; Pyruvaldehyde; Saliva | 2019 |
Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry: evaluation of blood specimen.
Topics: Blood Chemical Analysis; Calibration; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Glyoxal; Humans; Isotope Labeling; Perchlorates; Phenylenediamines; Pyruvaldehyde; Tandem Mass Spectrometry; Time Factors | 2014 |
Grape skin extracts from winemaking by-products as a source of trapping agents for reactive carbonyl species.
Topics: Antioxidants; Diabetes Mellitus, Type 2; Flavonoids; Food-Processing Industry; Fruit; Glycation End Products, Advanced; Glycosylation; Glyoxal; Industrial Waste; Plant Extracts; Pyruvaldehyde; Vitis; Wine | 2016 |
Post-Glucose Load Plasma α-Dicarbonyl Concentrations Are Increased in Individuals With Impaired Glucose Metabolism and Type 2 Diabetes: The CODAM Study.
Topics: Atherosclerosis; Blood Glucose; Chromatography, Liquid; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fasting; Female; Glucose Tolerance Test; Glycated Hemoglobin; Glyoxal; Humans; Hyperglycemia; Male; Mass Spectrometry; Middle Aged; Postprandial Period; Pyruvaldehyde | 2015 |
Aldehyde inhibition of antioxidant enzymes in the blood of diabetic patients.
Topics: Aldehydes; Animals; Antioxidants; Case-Control Studies; Cattle; Diabetes Mellitus, Type 2; Erythrocytes; Female; Glyoxal; Humans; Hypoglycemic Agents; Male; Malondialdehyde; Metformin; Middle Aged | 2016 |
[The C3-aldehydes and disorder of cellular metabolism: possible modes of normalization of carbohydrate metabolism].
Topics: Aldehydes; Antioxidants; Diabetes Mellitus, Type 2; Glucose; Glycation End Products, Advanced; Glyoxal; Humans; Hyperglycemia; Hypertension; Insulin; Oxidative Stress | 2015 |
Mass Spectrometric Analysis of Glyoxal and Methylglyoxal-Induced Modifications in Human Hemoglobin from Poorly Controlled Type 2 Diabetes Mellitus Patients.
Topics: Diabetes Mellitus, Type 2; Female; Glyoxal; Hemoglobins; Humans; Male; Middle Aged; Peptides; Pyruvaldehyde; Reference Standards; Smoking; Spectrometry, Mass, Electrospray Ionization | 2015 |
Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method.
Topics: Diabetes Mellitus, Type 2; Female; Gas Chromatography-Mass Spectrometry; Glyoxal; Humans; Male; Middle Aged; Pyruvaldehyde | 2003 |
Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress.
Topics: Aged; Arginine; Blood Glucose; Diabetes Mellitus, Type 2; Dialysis Solutions; Glycated Hemoglobin; Glycation End Products, Advanced; Glyoxal; Humans; Kidney Failure, Chronic; Lysine; Middle Aged; Oxidative Stress; Peritoneal Dialysis; Pyruvaldehyde | 2005 |
Increase in three alpha,beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction.
Topics: 2-Naphthylamine; Aging; Arginine; Chromatography, Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Glycation End Products, Advanced; Glyoxal; Humans; Kidney Failure, Chronic; Lysine; Mass Spectrometry; Matched-Pair Analysis; Middle Aged; Pyruvaldehyde; Reactive Oxygen Species; Sensitivity and Specificity; Uremia | 1999 |
Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.
Topics: Animals; Antibodies; Cattle; Chromatography, Affinity; Cross Reactions; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Glycation End Products, Advanced; Glyceraldehyde; Glyoxal; Humans; Immunoblotting; Kidney Failure, Chronic; Lysine; Maillard Reaction; Oxidation-Reduction; Pyruvaldehyde; Rabbits; Renal Dialysis | 2000 |